Results 21 to 30 of about 41,391 (317)

Efficacy of stepwise mini-incision microdissection testicular sperm extraction for nonobstructive azoospermia with varied etiologies. [PDF]

open access: yesAsian J Androl, 2023
Stepwise mini-incision microdissection testicular sperm extraction (mTESE) is a procedure that attempts to minimize testicular damage. However, the mini-incision approach may vary in patients with different etiologies.
Zhang YX   +9 more
europepmc   +2 more sources

Development of a predictive model for increasing sperm retrieval success by microdissection testicular sperm extraction in patients with nonobstructive azoospermia. [PDF]

open access: yesAsian J Androl, 2023
Microdissection testicular sperm extraction (micro-TESE) is widely used to treat nonobstructive azoospermia. However, a good prediction model is required to anticipate a successful sperm retrieval rate before performing micro-TESE.
Deng CY   +10 more
europepmc   +2 more sources

High sperm DNA fragmentation: do we have robust evidence to support antioxidants and testicular sperm extraction to improve fertility outcomes? a narrative review. [PDF]

open access: yesFront Endocrinol (Lausanne), 2023
To date, infertility affects 10% to 15% of couples worldwide. A male factor is estimated to account for up to 50% of cases. Oral supplementation with antioxidants could be helpful to improve sperm quality by reducing oxidative damage.
Romano M   +6 more
europepmc   +2 more sources

Nomogram based on a circular RNA biomarker for predicting the likelihood of successful sperm retrieval via microdissection testicular sperm extraction in patients with idiopathic non-obstructive azoospermia. [PDF]

open access: yesFront Endocrinol (Lausanne), 2022
Background Many circular RNAs (circRNAs) are specifically expressed in the testes and seminal plasma of patients with non-obstructive azoospermia (NOA), highlighting them as potential predictors of microdissection testicular sperm extraction (micro-TESE)
Shi S, Wang T, Wang L, Wang M.
europepmc   +2 more sources

Screening Y Chromosome Microdeletion in 1121 Men with Low Sperm Concentration and the Outcomes of Microdissection Testicular Sperm Extraction (mTESE) for Sperm Retrieval from Azoospermic Patients. [PDF]

open access: yesAppl Clin Genet, 2023
Background The Y chromosome has a specific region, namely the Azoospermia Factor (AZF) because azoospermia is typically reported in the microdeletion of the AZF region.
The Trinh S   +13 more
europepmc   +2 more sources

Testicular sperm extraction (TESE) outcomes in the context of malignant disease: a systematic review. [PDF]

open access: yesAsian J Androl, 2022
Advances in the oncology field have led to improved survival rates. Consequently, quality of life after remission is anticipated, which includes the possibility to conceive children.
Ogouma L   +7 more
europepmc   +2 more sources

Embryo development and live birth resulted from artificial oocyte activation after microdissection testicular sperm extraction with ICSI in patients with non-obstructive azoospermia. [PDF]

open access: yesFront Endocrinol (Lausanne), 2023
Introduction The application of microdissection testicular sperm extraction (micro-TESE) to retrieve the sperm of patients with non-obstructive azoospermia (NOA) has greatly increased. Patients with NOA often have poor quality sperm. Unfortunately, there
Zhang X   +6 more
europepmc   +2 more sources

Case Report: Longitudinal follow-up and testicular sperm extraction in a patient with a pathogenic NR5A1 (SF-1) frameshift variant: p.(Phe70Serfs*5). [PDF]

open access: yesFront Endocrinol (Lausanne), 2023
Background Steroidogenic factor 1 (SF-1), encoded by the nuclear receptor subfamily 5 group A member 1 (NR5A1) gene, is a transcriptional factor crucial for adrenal and gonadal organogenesis.
Teoli J   +10 more
europepmc   +2 more sources

Ex vivo microscopic testicular sperm extraction at the time of radical orchiectomy in men with nonobstructive azoospermia (NOA): a scoping review. [PDF]

open access: yesAsian J Androl
Testicular tumor is the most common solid malignancy in males under 40 years of age. This malignancy is known to have a negative impact on male fertility.
Giulioni C, Phuoc NHV, Cayan S.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy